Table 1 CLL / SLL and MCL Wave 1 qualitative study demographic and clinical characteristics
Characteristic | CLL/SLL (n = 20) | MCL (n = 21) |
|---|---|---|
Age | ||
 Mean (SD), years | 60.5 (6.78) | 62.4 (8.8) |
Sex, n (%) | ||
 Female | 14 (70) | 13 (62) |
 Male | 6 (30) | 7 (33) |
 Prefer not to answer | 0 (0) | 1 (5) |
Race/Ethnicity, n (%) | ||
 White | 19 (95) | 19 (90) |
 Hawaiian Native/Pacific Islander | 1 (5) | 0 (0) |
 Black/African American | 0 (0) | 1 (5) |
 Prefer not to answer | 0 (0) | 1 (5) |
Ethnicity, n (%) | ||
 Not Hispanic or Latino | 19 (95) | 17 (81) |
 Hispanic or Latino | 1 (5) | 4 (19) |
Education level, n (%) | ||
 High school/GED | 3 (15) | 3 (14) |
 Some college | 2 (10) | 6 (29) |
 Associate degree | 2 (10) | 1 (5) |
 Bachelor’s degree | 5 (25) | 7 (33) |
 Post-graduate degree | 8 (40) | 3 (14) |
 Prefer not to answer | 0 (0) | 1 (5) |
Comorbidities, n (%)a | ||
 Arthritis | 7 (35) | 4 (19) |
 Diabetes | 3 (15) | 1 (5) |
 Heart disease | 0 (0) | 4 (19) |
 Hypertension | 6 (30) | 10 (48) |
 Obesity | 2 (10) | 5 (24) |
 Osteoporosis | 3 (15) | 2 (10) |
 Psychological stress | 3 (15) | 3 (14) |
Treatment(s) receivedb | ||
 Any systematic therapy | 11 (55) | 19 (90) |
 Immunotherapy | 7 (35) | 7 (33) |
 Chemoimmunotherapy | 2 (10) | 4 (19) |
 Proteosome inhibitors | 1 (5) | 0 (0) |
 Bone marrow transplant | 0 (0) | 1 (5) |
 Other | 4 (20) | 4 (19) |
 No treatment | 4 (20) | 0 (0) |